Literature DB >> 7544320

Mutation analysis of ten exons of the CFTR gene in Greek cystic fibrosis patients: characterization of 74.5% of CF alleles including one novel mutation.

E Kanavakis1, M Tzetis, T Antoniadi, J Traeger-Synodinos, S Doudounakis, G Adam, N Matsaniotis, C Kattamis.   

Abstract

To initiate the complete characterization of mutations in the CFTR gene in Greek cystic fibrosis (CF) patients, we screened 184 patients for six relatively common mutations (delta F 508, G542X, G551D, 621 + 1 G-->T, N1303K, W1282X) using allele-specific hybridization and, in addition, analyzed exons 4, 5, 7, 8, 10, 11, 17b, 19, 20 and 21 using the method of denaturing gradient gel electrophoresis (DGGE). Six mutations accounted for 65.9% of the CF alleles in Greek patients, of which the delta F 508 mutation had a frequency of 52.7%. A further 15 previously described mutations accounted for another 8.3% CF alleles and one previously undescribed mutation (3272-4A-->G) was found in one chromosome. The W1282X mutation was not detected at all. Thus, so far, we have identified 21 mutations in the CFTR gene in Greek CF patients, accounting for 74.5% of the CF alleles.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7544320     DOI: 10.1007/bf00210426

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  14 in total

1.  Screening for five mutations detects 97% of cystic fibrosis (CF) chromosomes and predicts a carrier frequency of 1:29 in the Jewish Ashkenazi population.

Authors:  D Abeliovich; I P Lavon; I Lerer; T Cohen; C Springer; A Avital; G R Cutting
Journal:  Am J Hum Genet       Date:  1992-11       Impact factor: 11.025

2.  Cystic fibrosis in Greece: typing with DNA probes and identification of the common molecular defect.

Authors:  A Balassopoulou; D Loukopoulos; P Kollia; M Devoto; G Adam; S Arvanitakis; H Hadjisevastou
Journal:  Hum Genet       Date:  1990-09       Impact factor: 4.132

3.  Worldwide survey of the delta F508 mutation--report from the cystic fibrosis genetic analysis consortium.

Authors: 
Journal:  Am J Hum Genet       Date:  1990-08       Impact factor: 11.025

4.  Identification of the cystic fibrosis gene: genetic analysis.

Authors:  B Kerem; J M Rommens; J A Buchanan; D Markiewicz; T K Cox; A Chakravarti; M Buchwald; L C Tsui
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

5.  Prenatal diagnosis of beta-thalassaemia in Mediterranean populations by dot blot analysis with DNA amplification and allele specific oligonucleotide probes.

Authors:  M S Ristaldi; M Pirastu; C Rosatelli; G Monni; H Erlich; R Saiki; A Cao
Journal:  Prenat Diagn       Date:  1989-09       Impact factor: 3.050

6.  Generation of single-stranded DNA by the polymerase chain reaction and its application to direct sequencing of the HLA-DQA locus.

Authors:  U B Gyllensten; H A Erlich
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

7.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

8.  Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Authors:  J Zielenski; R Rozmahel; D Bozon; B Kerem; Z Grzelczak; J R Riordan; J Rommens; L C Tsui
Journal:  Genomics       Date:  1991-05       Impact factor: 5.736

9.  Identification of the cystic fibrosis gene: chromosome walking and jumping.

Authors:  J M Rommens; M C Iannuzzi; B Kerem; M L Drumm; G Melmer; M Dean; R Rozmahel; J L Cole; D Kennedy; N Hidaka
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

10.  Population variation of common cystic fibrosis mutations. The Cystic Fibrosis Genetic Analysis Consortium.

Authors: 
Journal:  Hum Mutat       Date:  1994       Impact factor: 4.878

View more
  2 in total

1.  The use of DHPLC (Denaturing High Performance Liquid Chromatography) in II level screening of the CFTR gene in Prenatal Diagnosis.

Authors:  Alvaro Mesoraca; Manuela Di Natale; Antonella Cima; Gianluca Di Giacomo; Monica Sarti; Maria Antonietta Barone; Domenico Bizzoco; Pietro Cignini; Luisa Mobili; Laura Dʼemidio; Claudio Giorlandino
Journal:  J Prenat Med       Date:  2010-07

2.  Molecular analysis using DHPLC of cystic fibrosis: increase of the mutation detection rate among the affected population in Central Italy.

Authors:  Maria Rosaria D'Apice; Stefano Gambardella; Mario Bengala; Silvia Russo; Anna Maria Nardone; Vincenzina Lucidi; Federica Sangiuolo; Giuseppe Novelli
Journal:  BMC Med Genet       Date:  2004-04-14       Impact factor: 2.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.